<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9BD3CF9B-3115-4441-ADBA-A8DAB7A4F59F"><gtr:id>9BD3CF9B-3115-4441-ADBA-A8DAB7A4F59F</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Lincoln</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BC68015C-8C93-472E-BF42-4C03B78FC6B0"><gtr:id>BC68015C-8C93-472E-BF42-4C03B78FC6B0</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Hayward</gtr:surname><gtr:orcidId>0000-0002-3549-6232</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/12E915D0-DC1A-43EE-9200-7CBA0263C599"><gtr:id>12E915D0-DC1A-43EE-9200-7CBA0263C599</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Morris</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A7625EF3-ECC0-45F1-92FE-A8B0CCD0E91F"><gtr:id>A7625EF3-ECC0-45F1-92FE-A8B0CCD0E91F</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Capewell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7DBDFB1D-AB5D-4CEA-9C32-2F1A43E25C20"><gtr:id>7DBDFB1D-AB5D-4CEA-9C32-2F1A43E25C20</gtr:id><gtr:firstName>Irene</gtr:firstName><gtr:surname>Petersen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F0C0B1B1-4A55-45C3-88FC-9B6C29246B5E"><gtr:id>F0C0B1B1-4A55-45C3-88FC-9B6C29246B5E</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Whincup</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501307"><gtr:id>B3C97A51-C16E-479A-826C-C52C40834D5A</gtr:id><gtr:title>Analysing the decline in the British Coronary Heart Disease epidemic</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501307</gtr:grantReference><gtr:abstractText>Death rates for coronary heart disease (CHD) in the UK have halved since 1980, but CHD is still the commonest cause of death. The decrease since 1980 may be because fewer people now get CHD in the first place, or because more people survive after experiencing CHD, or both. If fewer people now get CHD, this may be due to changes in risk factors in the population (for example, fewer people now smoke). If survival after CHD is better, it will mainly be due to more effective treatment by hospitals or by family doctors, or both. Since 2000, the National Health Service has greatly increased its expenditure on CHD, and the UK spends more per head than any other European country. However most of the spending increase has been concentrated on facilities for people in hospital with CHD. It is therefore important that we understand the main reasons why CHD has fallen in the last two decades. Then government departments will be able to make informed choices about how they best allocate future expenditure, to bring about further decreases in deaths due to CHD. We will analyse three data sets; (i) the British Regional Heart Study which has followed up over 7000 British men for 25 years; (ii) the General Practice Research Database (and the similar THIN database), which has captured computer-recorded information on patients from hundreds of general practices since 1990, and (iii) the Health Survey for England (HSE), which surveys about 19,000 people every year, and in 1994, 1998 and 2003 concentrated on issues concerning cardiovascular disease. From these studies, we will describe trends in heart disease rates, in risk factors, treatment rates, and survival rates after heart disease. Using a computer model called IMPACT, we will then estimate the contribution of changes in risk factors, and increases in treatment, in decreasing the CHD epidemic. We will work with the National Heart Forum, a well-established and influential advocacy group concerning government health policy, to help guide our analysis, and to disseminate our findings.</gtr:abstractText><gtr:technicalSummary>Mortality for coronary heart disease (CHD) in the UK has halved since 1980, but CHD is still the commonest cause of death. The decrease since 1980 may be due to lower incidence of CHD, or because of better survival and prognosis after CHD, or both. Lower incidence may be due to changes in risk factors in the population: for example, the decline in smoking. Improved prognosis following CHD will mainly be attributable to wider use of proven treatments in secondary and primary care. Since the publication in 2000 of the National Service Framework for CHD, health service expenditure on CHD has greatly increased, and the UK now spends more per head than any other European country. However most of the spending increase has been concentrated on treatment for CHD, in particular on an expansion in revascularisation services. It is therefore important that we understand the main reasons why CHD has fallen in the last two decades. Then government departments will be able to make evidence-based choices concerning resource allocation, to bring about further decreases in CHD mortality. We will analyse three data sets; (i) the British Regional Heart Study which has followed over 7000 British men for 25 years for CHD incidence and has collected physical and biochemical measures, and has administered seven questionnaires concerning health status, use of treatment, health behaviour etc; (ii) the General Practice Research Database (and the similar THIN database), which has captured computer-recorded information on consultations by patients from over 700 general practices since 1990, and (iii) the Health Survey for England (HSE), which annually surveys about 19,000 people, and in 1994, 1998 and 2003 concentrated on cardiovascular disease. From these studies, we will describe trends in CHD, in risk factors, treatment rates, and survival rates after CHD. In particular we will evaluate the relationship between risk factor changes, treatment and trends in CHD. Using the established IMPACT model, we will then estimate the contribution of changes in risk factors, and increases in treatment, in decreasing the CHD epidemic. We will work with the National Heart Forum, a well-established and influential advocacy group concerning government health policy, to help guide our analysis, and to disseminate our findings.</gtr:technicalSummary><gtr:fund><gtr:end>2008-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>130708</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Poster</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>A906BD00-D3D9-4B60-B990-6A920F990299</gtr:id><gtr:impact>Presented poster at Europrevent07, Madrid, Spain. Conference of approx 1000 clinical and non-clinical academics interested in prevention of cardiovascular disease.

None</gtr:impact><gtr:outcomeId>889810E2442</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F70BBA12-EF74-4EF0-8EA4-072769D84D51</gtr:id><gtr:impact>I gave 15 minute talk (5 minutes of questions) at International Epidemiological Association/ Society for Social Medicine in Cork City, ROI. Audience of roughly 300, mainly epidemiologists.

None</gtr:impact><gtr:outcomeId>6C48B845572</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>154000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Health Services and Health of the Public Research Fellowship</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DC8FAFF4-BF5F-4D41-B308-5129246848FF</gtr:id><gtr:outcomeId>DA5231199600</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A form of analysis which has been incorporated into &amp;quot;Do files&amp;quot; in the Stata statistical package. However the publication could allow anyone to develop alternative methods for accomplishing the same</gtr:description><gtr:id>82F5ECCB-18F3-4B7D-9FF3-4F8131149501</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>7B058E48DD9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>analysis tool</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>https://iris.ucl.ac.uk/iris/publication/424322/1</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>70CD87AF-9CBD-4459-AF18-8272633FD08B</gtr:id><gtr:title>Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study.</gtr:title><gtr:parentPublicationTitle>European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology &amp; Prevention and Cardiac Rehabilitation and Exercise Physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e22a434f6da38237bd0a006ccd2a7f3"><gtr:id>3e22a434f6da38237bd0a006ccd2a7f3</gtr:id><gtr:otherNames>Hardoon SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1741-8267</gtr:issn><gtr:outcomeId>tiSf978xd6U</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>382BD3BB-84E0-4728-998B-427679D524F7</gtr:id><gtr:title>Rising adiposity curbing decline in the incidence of myocardial infarction: 20-year follow-up of British men and women in the Whitehall II cohort.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e22a434f6da38237bd0a006ccd2a7f3"><gtr:id>3e22a434f6da38237bd0a006ccd2a7f3</gtr:id><gtr:otherNames>Hardoon SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>pm_14979_29_21653562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B99EF677-8728-4099-85F9-03FE8531381B</gtr:id><gtr:title>Trends in longer-term survival following an acute myocardial infarction and prescribing of evidenced-based medications in primary care in the UK from 1991: a longitudinal population-based study.</gtr:title><gtr:parentPublicationTitle>Journal of epidemiology and community health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e22a434f6da38237bd0a006ccd2a7f3"><gtr:id>3e22a434f6da38237bd0a006ccd2a7f3</gtr:id><gtr:otherNames>Hardoon SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0143-005X</gtr:issn><gtr:outcomeId>cXyhXzZsQjz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>052A015B-E229-4B14-BEFD-21E6E60711F6</gtr:id><gtr:title>Is the recent rise in type 2 diabetes incidence from 1984 to 2007 explained by the trend in increasing BMI?: evidence from a prospective study of British men.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e22a434f6da38237bd0a006ccd2a7f3"><gtr:id>3e22a434f6da38237bd0a006ccd2a7f3</gtr:id><gtr:otherNames>Hardoon SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>pm_14979_29_20413526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82EE44A8-396C-4DC2-9EB5-DE9FC9632823</gtr:id><gtr:title>How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e22a434f6da38237bd0a006ccd2a7f3"><gtr:id>3e22a434f6da38237bd0a006ccd2a7f3</gtr:id><gtr:otherNames>Hardoon SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>9B569E630FB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501307</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>